Eva Renee Barnett, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 24,506 shares at $28.80 ($712K) on 2024-04-17, disclosed to the SEC on 2024-04-19.
Open-market sale of $712k IMVT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.80 | 9,479 | $273K | 38.3% |
| 2 | $28.80 | 9,479 | $273K | 38.3% |
| 3 | $29.94 | 2,774 | $83K | 11.7% |
| 4 | $29.94 | 2,774 | $83K | 11.7% |
| Total | $29.06 avg | 24,506 | $712K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $117K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $107K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $198K | — | Filing → |